Cisplatin in the treatment of metastatic breast carcinoma A prospective randomized trial of two dosage schedules
Phase II trial of PCNU in refractory advanced breast cancer
Randomized evaluation of combination chemotherapy vs. observation alone following response or stabilization after oophorectomy for metastatic breast cancer in premenopausal women
A statistical note
Hexamethylmelamine as a single agent in the treatment of small-cell carcinoma of the lung
Phase II evaluation of 4′-(9-acridinylamino)-methanesulfon-m-anisidide (m-AMSA) in patients with gastric adenocarcinoma
Phase II trial of methyl-CCNU, vincristine, 5-fluorouracil, and streptozotocin (MOF-Strep) in patients with disseminated pancreatic carcinoma
Alternative approaches to evaluating the impact of local control on survival
Scanning with L-[13N]glutamate Assessment of the response to chemotherapy of a patient with embryonal rhabdomyosarcoma
A phase II trial of m-AMSA in the treatment of advanced gynecologic malignancies
Interferon in cancer Faith, hope, and reality
The effect of patient position on radiotherapy protocol deviations in the treatment of acute lymphocytic leukemia
Hydroxyurea versus busulfan in the treatment of chronic myelogenous leukemia
Reasons for failure of MOPP to cure Hodgkin's disease The importance of dose and schedule
The modification of melphalan toxicity in tumor bearing mice by S-2-(3-aminopropylamino)-ethylphosphorothioic acid (WR2721)
Fast Neutrons in the Treatment of Cancer
Advances in Cyclic Nucleotide Research
Interferon 2, 1980
The Nitroquinolines
Doxorubicin
Pituitary Adenomas
Short-Term Tests for Chemical Carcinogens
Methods and Impact of Controlled Therapeutic Trials in Cancer